
4519.T-19.25%23.6%

ALNY-50.86%23.6%

ARWR+68.44%23.6%

WVE-57.63%23.6%

2257.HK-75.21%4.7%

NVO-34.94%1.0%
As of Oct 9, 2026, 4:27 AM ET
GLP-1 Long '26: RNA Fat Redistribution Constituents
Alnylam Pharmaceuticals, Inc.ALNY | 23.6% | 0.05% | -12.07% | -12.97% | -2.88% | -43.54% | -32.56% | -15.85% | -50.86% | -17.21% | 10.23% | $30.04B |
Arrowhead Pharmaceuticals, Inc.ARWR | 23.6% | -1.20% | -7.21% | -26.49% | -6.25% | -8.51% | -4.00% | 378.64% | 68.44% | 237.07% | 0.68% | $8.56B |
Chugai Pharmaceutical Co., Ltd.4519.T | 23.6% | 0.10% | -4.46% | -8.31% | -1.26% | -26.84% | -42.32% | -13.81% | -19.25% | -17.55% | 10.47% | $63.62B |
Wave Life Sciences Ltd.WVE | 23.6% | -1.98% | -5.45% | -27.86% | -10.57% | -79.59% | -75.09% | -54.16% | -57.63% | -56.62% | -22.89% | $683.8M |
Sirnaomics Ltd.2257.HK | 4.7% | -4.94% | 1.45% | -0.72% | -1.21% | -51.45% | -46.21% | 7.93% | -75.21% | -10.78% | -95.22% | $52.1M |
Novo Nordisk A/SNVO | 1.0% | -0.21% | -1.37% | -14.32% | 2.09% | -24.96% | 1.95% | -44.05% | -34.94% | -67.42% | -19.35% | $169.54B |
| Theme return | — | -0.95% | -6.83% | -19.55% | -5.18% | -41.17% | -38.96% | 24.73% | -26.20% | 13.43% | 46.53% | — |
| Average | 16.7% | -1.36% | -4.85% | -15.11% | -3.35% | -39.15% | -33.04% | 43.12% | -28.24% | 11.25% | -19.35% | $45.42B |
| Median | 23.6% | -0.70% | -4.95% | -13.64% | -2.07% | -35.19% | -37.44% | -14.83% | -42.90% | -17.38% | -9.33% | $19.30B |
| Std Dev | 9.8% | 1.76% | 4.28% | 9.58% | 4.07% | 22.72% | 26.13% | 151.43% | 46.64% | 103.21% | 36.36% | $59.71B |
| Min | 1.0% | -4.94% | -12.07% | -27.86% | -10.57% | -79.59% | -75.09% | -54.16% | -75.21% | -67.42% | -95.22% | $52.1M |
| Max | 23.6% | 0.10% | 1.45% | -0.72% | 2.09% | -8.51% | 1.95% | 378.64% | 68.44% | 237.07% | 10.47% | $169.54B |
| % Positive Tickers | 33.33% | 16.67% | 0.00% | 16.67% | 0.00% | 16.67% | 33.33% | 16.67% | 16.67% | 50.00% |